The sequence of the first five N-terminal amino acids was determined and was found to be His-Ser-Gln-Gly-Thr.

Greater than 98.0% as determined by:(a) Analysis by RP-HPLC.(b) Analysis by SDS-PAGE.

Sterile Filtered White lyophilized (freeze-dried) powder.

Each mg of recombinant Glucagon was formulated with 100mg of lactose.

The activity is determind by comparing, under certain conditions, the hyperglycemic effect it produces with that produced by the international standard or by reference preparation calibrated in IU and is found to be 1 IU/mg.

Description

Glucagon Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 29 amino acids and having a molecular mass of 3483 Dalton. The Glucagon is purified by proprietary chromatographic techniques.

Stability & Storage

Storage/Stability

Lyophilized Glucagon although stable at room temperature for 3 weeks, should be stored at 4^°C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).

The sequence of the first five N-terminal amino acids was determined and was found to be His-Ser-Gln-Gly-Thr.

Greater than 98.0% as determined by:(a) Analysis by RP-HPLC.(b) Analysis by SDS-PAGE.

Sterile Filtered White lyophilized (freeze-dried) powder.

Each mg of recombinant Glucagon was formulated with 100mg of lactose.

Description

Stability & Storage

Storage/Stability

Lyophilized Glucagon although stable at room temperature for 3 weeks, should be stored at 4^°C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).

Size	500 µg, 1000 µg
Estimated Lead Time	2-3 weeks
Species	Human
Accession Number	P01275
Gene Id	2641
Protein Name / Synonyms	GLP1, GLP2, GRPP.
Expressed Region	The sequence of the first five N-terminal amino acids was determined and was found to be His-Ser-Gln-Gly-Thr.
Expression System	E. coli
Purity	Greater than 98.0% as determined by:(a) Analysis by RP-HPLC.(b) Analysis by SDS-PAGE.
Format	Sterile Filtered White lyophilized (freeze-dried) powder.
Formulation	Each mg of recombinant Glucagon was formulated with 100mg of lactose.
Activity	The activity is determind by comparing, under certain conditions, the hyperglycemic effect it produces with that produced by the international standard or by reference preparation calibrated in IU and is found to be 1 IU/mg.
Research Area	Apoptosis
Shipping Type	Ambient temperature
Storage	-20°C

Size	500 µg, 1000 µg
Estimated Lead Time	2-3 weeks
Species	Human
Accession Number	P01275
Gene Id	2641
Protein Name / Synonyms	GLP1, GLP2, GRPP.
Expressed Region	The sequence of the first five N-terminal amino acids was determined and was found to be His-Ser-Gln-Gly-Thr.
Expression System	E. coli
Purity	Greater than 98.0% as determined by:(a) Analysis by RP-HPLC.(b) Analysis by SDS-PAGE.
Format	Sterile Filtered White lyophilized (freeze-dried) powder.
Formulation	Each mg of recombinant Glucagon was formulated with 100mg of lactose.
Activity	The activity is determind by comparing, under certain conditions, the hyperglycemic effect it produces with that produced by the international standard or by reference preparation calibrated in IU and is found to be 1 IU/mg.
Research Area	Apoptosis
Shipping Type	Ambient temperature
Storage	-20°C

Featured Products

Glucagon, Human Recombinant

Product Description

Specifications

Description

Stability & Storage

Featured Products

Glucagon, Human Recombinant

Product Description

Specifications

Description

Stability & Storage

Glucagon, Human Recombinant

Glucagon, Human Recombinant

Featured Products

Glucagon, Human Recombinant

Product Description

Specifications

Description

Stability & Storage

Documents

Reviews

Ask A Question

Featured Products

Glucagon, Human Recombinant

Product Description

Specifications

Description

Stability & Storage

Documents

Reviews

Ask A Question

Glucagon, Human Recombinant

Glucagon, Human Recombinant